Meeting of the Medical Imaging Drugs Advisory Committee: Gadolinium Retention Following Contrast MRI and Pregnancy Utilization

Title	Meeting of the Medical Imaging Drugs Advisory Committee: Gadolinium Retention Following Contrast MRI and Pregnancy Utilization
Date	Friday, September 8, 2017
Link	View the Advisory Committee Meeting Materials here
Related Links	Gadolinium-Based Contrast Agents (GBCAs) Use in Pregnancy Completed ARIA Assessments & Impact
Medical Product	gadolinium-based contrast agent (GBCA)
Health Outcome	exposure in pregnancy

Search form